company background image
300149 logo

Chempartner Pharmatech SZSE:300149 Stock Report

Last Price

CN¥4.67

Market Cap

CN¥2.3b

7D

-13.7%

1Y

-54.7%

Updated

18 Apr, 2024

Data

Company Financials

Chempartner Pharmatech Co., Ltd.

SZSE:300149 Stock Report

Market Cap: CN¥2.3b

300149 Stock Overview

Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide.

300149 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Chempartner Pharmatech Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Chempartner Pharmatech
Historical stock prices
Current Share PriceCN¥4.67
52 Week HighCN¥10.55
52 Week LowCN¥3.68
Beta0.64
1 Month Change-23.19%
3 Month Change-30.09%
1 Year Change-54.75%
3 Year Change-66.93%
5 Year Change-70.61%
Change since IPO-30.63%

Recent News & Updates

Chempartner Pharmatech Co., Ltd.'s (SZSE:300149) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Mar 08
Chempartner Pharmatech Co., Ltd.'s (SZSE:300149) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Recent updates

Chempartner Pharmatech Co., Ltd.'s (SZSE:300149) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Mar 08
Chempartner Pharmatech Co., Ltd.'s (SZSE:300149) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Shareholder Returns

300149CN BiotechsCN Market
7D-13.7%-1.9%-0.2%
1Y-54.7%-26.9%-17.8%

Return vs Industry: 300149 underperformed the CN Biotechs industry which returned -26.9% over the past year.

Return vs Market: 300149 underperformed the CN Market which returned -17.8% over the past year.

Price Volatility

Is 300149's price volatile compared to industry and market?
300149 volatility
300149 Average Weekly Movement11.3%
Biotechs Industry Average Movement8.0%
Market Average Movement8.9%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.4%

Stable Share Price: 300149's share price has been volatile over the past 3 months.

Volatility Over Time: 300149's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
20002,072Ji Guo Zhangwww.cppt.com.cn

Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services.

Chempartner Pharmatech Co., Ltd. Fundamentals Summary

How do Chempartner Pharmatech's earnings and revenue compare to its market cap?
300149 fundamental statistics
Market capCN¥2.33b
Earnings (TTM)-CN¥686.01m
Revenue (TTM)CN¥1.14b

2.0x

P/S Ratio

-3.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300149 income statement (TTM)
RevenueCN¥1.14b
Cost of RevenueCN¥984.98m
Gross ProfitCN¥155.55m
Other ExpensesCN¥841.56m
Earnings-CN¥686.01m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Apr 26, 2024

Earnings per share (EPS)-1.38
Gross Margin13.64%
Net Profit Margin-60.15%
Debt/Equity Ratio7.5%

How did 300149 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.